Cryptocurrencies
Anitoa Extends Its SARS-CoV-2 Rapid Nucleic Acid Test Capability To Include The Detection Of Omicron
SUNNYVALE, Calif., Jan. 7, 2022 /PRNewswire/ — Anitoa Systems, a Silicon Valley biotech company has added its SARS-CoV2 Rapid Nucleic Acid Test portfolio to include the detection of Omicron and Delta mutations, which are designated by Read more…